Radiological Biomarkers in MRI directed Rectal Cancer Radiotherapy Volume Delineation.

extramural venous invasion magnetic resonance imaging radiological biomarkers radiotherapy rectal cancer target volume delineation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Oct 2023
Historique:
received: 05 09 2023
revised: 18 10 2023
accepted: 25 10 2023
medline: 14 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Our study evaluated whether an MRI reporting system highlighting areas of contiguous and discontinuous extramural venous invasion (EMVI) can improve the accuracy of gross tumour volume (GTV) delineation. Initially, 27 consecutive patients with locally advanced rectal cancer treated between 2012 and 2014 were evaluated. We used an MRI reporting proforma that documented the position of the primary tumour, lymph nodes and EMVI. The new GTVs delineated were compared with historical radiotherapy treatment volumes to identify the frequency of GTV geographical miss. We observed that the delineation of involved nodes and areas of EMVI was more likely to represent sources of uncertainty wherein nodal GTV geographical miss was evident in 5 out of 27 patients (19%). Complete EMVI GTV geographical miss occurred in two patients (7%). We re-evaluated our radiotherapy practice in a further 27 patients after the implementation of a modified MRI reporting system. An improvement was seen; nodal miss was observed in two patients (7%) and partial EMVI miss in one patient (4%), although these areas were encompassed in the planning target volume (PTV). Our study shows that extramural venous invasion and involved nodes need to be highlighted on MRI to improve the accuracy of rectal cancer GTV delineation.

Identifiants

pubmed: 37958350
pii: cancers15215176
doi: 10.3390/cancers15215176
pmc: PMC10649318
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : The Royal Marsden Cancer Charity, The Syncona Foundation and Red Trouser Day
Organisme : NHS funding from the Royal Marsden/ICR NIHR Biomedical Research Centre

Références

N Engl J Med. 2004 Oct 21;351(17):1731-40
pubmed: 15496622
Br J Surg. 1980 Jun;67(6):439-42
pubmed: 7388345
J Clin Oncol. 2012 May 20;30(15):1770-6
pubmed: 22493423
Radiol Med. 2019 May;124(5):331-338
pubmed: 30560501
Ann Surg Oncol. 2011 Jun;18(6):1590-8
pubmed: 21207164
Eur J Surg Oncol. 2017 Jul;43(7):1324-1329
pubmed: 28363512
Eur Radiol. 2023 Feb;33(2):854-862
pubmed: 35980431
N Engl J Med. 2006 Sep 14;355(11):1114-23
pubmed: 16971718
Clin Oncol (R Coll Radiol). 2020 Jan;32(1):35-42
pubmed: 31362843
Ann Oncol. 2014 Apr;25(4):858-863
pubmed: 24667718
J Clin Oncol. 2005 Dec 1;23(34):8688-96
pubmed: 16246976
Radiother Oncol. 2016 Aug;120(2):195-201
pubmed: 27528121
Br J Surg. 2012 Jul;99(7):897-909
pubmed: 22539154
Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):371-83
pubmed: 11567811
Clin Transl Radiat Oncol. 2018 Jun 11;11:33-39
pubmed: 29928706
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):824-30
pubmed: 19117696
Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):709-16
pubmed: 16242252
Br J Cancer. 2017 Nov 7;117(10):1478-1485
pubmed: 28934761
Dis Colon Rectum. 1997 Jan;40(1):3-10
pubmed: 9102257
Cancer. 2012 Feb 1;118(3):628-38
pubmed: 21751188
Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8
pubmed: 15383798
Lancet Oncol. 2010 Sep;11(9):835-44
pubmed: 20692872
Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):843-56
pubmed: 11020583
J Clin Oncol. 2011 Dec 10;29(35):4633-40
pubmed: 22067400
Lancet Oncol. 2007 Jul;8(7):625-33
pubmed: 17613424
Clin Oncol (R Coll Radiol). 2008 Mar;20(2):176-83
pubmed: 18248971
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):74-80
pubmed: 22763027
J Clin Oncol. 2006 Oct 1;24(28):4620-5
pubmed: 17008704
Lancet Oncol. 2015 Aug;16(8):919-27
pubmed: 26156652
Br J Cancer. 2017 Jun 6;116(12):1513-1519
pubmed: 28449006
Cancer Radiother. 2019 Jun;23(3):216-221
pubmed: 31109840
Acta Oncol. 2016 Dec;55(12):1392-1399
pubmed: 27762654

Auteurs

Charleen Chan Wah Hak (C)

The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.

Svetlana Balyasnikova (S)

Kingston Hospital NHS Foundation Trust, Kingston upon Thames KT2 7QB, UK.

Samuel Withey (S)

The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.

Diana Tait (D)

The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.

Gina Brown (G)

Department of Surgery and Cancer, Hammersmith Campus, Imperial College, London W12 0HS, UK.

Irene Chong (I)

The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.

Classifications MeSH